1st Quarter - Amendment

AMERICAN SOCIETY OF ANESTHESIOLOGISTS for AMERICAN SOCIETY OF ANESTHESIOLOGISTS

Firm
Client
Income
—
Expenses
$260,000
Expense method
C: businesses, Internal Revenue Code section 162(e)

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
1st Quarter - Report Apr 19, 2016 $120,000 Replaced
1st Quarter - Amendment (this page) Jul 19, 2016 $260,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 2603, Saving Lives, Saving Costs S.1475, Saving Lives, Saving Costs H.R. 1152, Preservation of Antibiotics for Medical Treatment Act of 2015 S.621, Preventing Antibiotic Resistance Act of 2015 H.R. 1455, Speeding Access to Already Improved Pharmaceuticals Act of 2015 H.R.3014, Medical Controlled Substances Transportation Act of 2015 S. 524, Comprehensive Addiction & Recovery Act of 2016 H.R. 1725, National All Schedules Prescription Electronic Reporting Act 21st Century Cures Initiative Drug Shortages - FDA, DEA, HHS, CMS, GAO, House Energy and Commerce Committee, Senate HELP Committee DEA Scheduling Propofol Comparative Effectiveness Research HITECH Implementation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Safe Use Initiative Pain Management FTC Letters to States re: Interventional Pain Medicine & Advanced Practice Nurses & Competition in Healthcare Pediatric Anesthesia Research Funding Scope of Practice FDA Operating Room Fires State Exchanges pursuant to PPACA Naloxone ICD-10-CM/PCS and proposed delay of implementation date FDA Opioids Prescription Drug Abuse FDA Network of Experts NIH Interagency Pain Research Coordinating Committee FDA SMART TOTS - pediatric anesthesia research USP - US Pharmacopeia National Pain Strategy Nondiscrimination FDA Sugammadex Compounding FDA Nominations to Advisory Committees (Anesthesia Drugs, Anesthesia Devices, Compounding) Agency for Healthcare Research and Quality (AHRQ) funding

LobbyistCovered position, as disclosed
MANUEL BONILLA —
NORA BAUMEISTER MATUS —
SHARON MERRICK —
LISA PEARLSTEIN —
MATTHEW T POPOVICH —
ASHLEY WALTON —

Contacted: SENATE; Defense, Dept of (DOD); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Occupational Safety & Health Administration (OSHA); Federal Trade Commission (FTC); HOUSE OF REPRESENTATIVES; Executive Office of the President (EOP); Health & Human Services, Dept of (HHS); Government Accountability Office (GAO); Drug Enforcement Administration (DEA); Veterans Affairs, Dept of (VA); Justice, Dept of (DOJ); Natl Institutes of Health (NIH); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 1455 (114th), H.R. 3014 (114th), H.R. 1725 (114th), S. 524 (114th), S. 621 (114th), H.R. 1741 (114th), H.R. 1152 (114th), S. 1475 (114th), H.R. 2603 (114th)

Veterans VET

Veterans Affairs Advance Practice Registered Nurses - "VHA Nursing Handbook" H.R. 1247, Improving Access to Quality Care Act of 2015 S.297, Frontlines to Lifelines Act S.2279, Veterans Health Care Staffing Improvement Act H.R. 4134, Veterans Health Care Staffing Improvement Act

LobbyistCovered position, as disclosed
MANUEL BONILLA —
NORA BAUMEISTER MATUS —
SHARON MERRICK —
LISA PEARLSTEIN —
MATTHEW T POPOVICH —
ASHLEY WALTON —

Contacted: Drug Enforcement Administration (DEA); Food & Drug Administration (FDA); Veterans Affairs, Dept of (VA); Federal Trade Commission (FTC); SENATE; HOUSE OF REPRESENTATIVES; Occupational Safety & Health Administration (OSHA); Justice, Dept of (DOJ); Government Accountability Office (GAO); Executive Office of the President (EOP); Office of Management & Budget (OMB); Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS); Natl Institutes of Health (NIH); Defense, Dept of (DOD)

Bills named: S. 297 (114th), H.R. 1247 (114th), S. 2279 (114th), H.R. 4134 (114th)

Medicare/Medicaid MMM

H.R. 1741, Truth in Healthcare Marketing Act of 2015 H.R. 2, Medicare Access and CHP Reauthorization Act H.R. 1470, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2015 S.810, Medicare SGR Repeal and Beneficiary Access Improvement Act of 2015 H.R. 1190, Protecting Seniors' Access to Medicare Act of 2015 S.141, Protecting Seniors' Access to Medicare Act of 2015 H.R. 2138, Medicare Access to Rural Anesthesiology Act of 2015 H.R. 1220, Removing Barriers to Colorectal Screening Act of 2015 S.624, Removing Barriers to Colorectal Screening Act of 2015 H.R. 887, Electronic Health Fairness Act of 2015 S. 679, Quality Data, Quality Healthcare Act of 2015 H.R. 1247, Improving Access to Quality Care Act of 2015 Hospital Improvements for Payment Act Budget Control Act of 2011: P.L. 112-25 Historical Medicare payment undervaluation for anesthesiology services (33% problem) Anesthesia Conversion Factor Perioperative Surgical Home Model Medicare Reform, Payment Issues: Medicare Sustainable Growth Rate repeal Bundled payments CMS Interpretive Guidelines: Hospital Conditions of Participation Related to Anesthesia Services 2016 Medicare Physician Fee Schedule Rule CMS decision to decrease values of interlaminar epidural injections CMS Value-Based purchasing CMS Medicare Data Final Rule CMS Proposed Rule on Sunshine Act Conditions of Participation - Anesthesia services, opt-outs, supervision Physician Quality Reporting System, PPACA, Sec. 3007 Quality Modifier implementation President Obama's deficit reduction plans, IPAB cuts Accountable Care Organizations Graduate Medical Education Cuts HHS Plan for Retrospective Review of Existing Rules 2011 - Conditions of Participation Value-based modifier - PPACA Debt ceiling- Medicare sequestration E-Prescribing QCDR- Qualified Clinical Data Registry CMS Meaningful Use Stage 3

LobbyistCovered position, as disclosed
MANUEL BONILLA —
NORA BAUMEISTER MATUS —
SHARON MERRICK —
LISA PEARLSTEIN —
MATTHEW T POPOVICH —
ASHLEY WALTON —

Contacted: Centers For Medicare and Medicaid Services (CMS); Federal Trade Commission (FTC); Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; SENATE; Executive Office of the President (EOP); Office of Management & Budget (OMB); Food & Drug Administration (FDA); Natl Institutes of Health (NIH); Justice, Dept of (DOJ); Veterans Affairs, Dept of (VA); Government Accountability Office (GAO); Health & Human Services, Dept of (HHS); Occupational Safety & Health Administration (OSHA); Drug Enforcement Administration (DEA)

Bills named: S. 679 (114th), H.R. 2138 (114th), H.R. 887 (114th), S. 810 (114th), H.R. 1470 (114th), H.R. 1247 (114th), S. 624 (114th), H.R. 1220 (114th), H.R. 1190 (114th), S. 141 (114th), H.R. 2 (114th), H.R. 1741 (114th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.